Pipequaline

DB13991ExperimentalSmall molecule

Pipequaline is an anticonflict & anticonvulsant quinoline derivative. It is an anxiolytic drug that was never marketed. It presents a unique chemical structure that does not follow the structural properties... Pipequaline has a similar pharmacological profile to the reported for the benzodiazepines.

Mechanism: Pharmacologically active on GABA(A) Receptor Benzodiazepine Binding Site
Curator reviewed
Formula / weight: C₂₂H₂₄N₂ · 316.448 g/mol (avg)
Code names: PK-8165

Resolves to

Compound

UNIIJ3S205V4I2CAS77472-98-1ChEMBLCHEMBL2105206

Structure

InChIKeyAMEWZCMTSIONOX-UHFFFAOYSA-NSMILESC(CC1=C2C=CC=CC2=NC(=C1)C1=CC=CC=C1)C1CCNCC1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Pipequaline, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account